Preoperative Chemoradiotherapy Versus Upfront Surgery for Early-Onset Clinical Stage II–III Rectal Cancer: A Multicenter Asian Registry Study
This multicenter Asian registry study found that preoperative chemoradiotherapy did not significantly improve disease-free or overall survival compared to upfront surgery in patients with early-onset clinical stage II–III rectal cancer who underwent surgical resection.